Skip to main content

ADVERTISEMENT

Frank Saltiel, MD

06/19/2008
Disclosure: Dr. Saltiel and Dr. Fischell hold a financial interest in Ostial Solutions, Inc., which owns the Ostial Pro. Introduction As the field of interventional cardiology has continued to progress, the need for lesion-specific...
Disclosure: Dr. Saltiel and Dr. Fischell hold a financial interest in Ostial Solutions, Inc., which owns the Ostial Pro. Introduction As the field of interventional cardiology has continued to progress, the need for lesion-specific...
Disclosure: Dr. Saltiel and Dr....
06/19/2008
Cath Lab Digest
Feature
06/19/2008
Disclosure: Dr. Saltiel and Dr. Fischell hold a financial interest in Ostial Solutions, Inc., which owns the Ostial Pro. Introduction As the field of interventional cardiology has continued to progress, the need for lesion-specific...
Disclosure: Dr. Saltiel and Dr. Fischell hold a financial interest in Ostial Solutions, Inc., which owns the Ostial Pro. Introduction As the field of interventional cardiology has continued to progress, the need for lesion-specific...
Disclosure: Dr. Saltiel and Dr....
06/19/2008
Cath Lab Digest
Original Contribution
07/10/2023
Percutaneous coronary intervention (PCI) of saphenous vein grafts (SVG) can be challenging due to no reflow phenomenon from distal embolization of debris and microvascular vasoconstriction, resulting in myocardial injury post-procedure....
Percutaneous coronary intervention (PCI) of saphenous vein grafts (SVG) can be challenging due to no reflow phenomenon from distal embolization of debris and microvascular vasoconstriction, resulting in myocardial injury post-procedure....
Percutaneous coronary...
07/10/2023
Journal of Invasive Cardiology